Umban, Venerando S.
HRN: 26-27-38 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/17/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/17/2025
11/24/2025
IV
2.25g
Q8
Nonhealing Wound
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: No Wrong Dose
Final appropriateness: No Wrong Dose
Overall appropriateness: No Adjust Dose According To EGFR